Analog-based free testosterone test results linked to total testosterone concentrations, not free testosterone concentrations

Clinical Chemistry

Volumn 54, Issue 3, 2008, Pages 512-516

  Fritz, Kristofer S ^a   McKean, Alastair J S ^a   Nelson, Jerald C ^a   Wilcox, R Bruce ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE BINDING PROTEIN; TESTOSTERONE;

ADULT; ANALYTIC METHOD; ARTICLE; CONCENTRATION (PARAMETERS); COVARIANCE; DIALYSATE LEVEL; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; LABORATORY TEST; MALE; NORMAL HUMAN; TESTOSTERONE BLOOD LEVEL;

ADULT; DIALYSIS; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PROTEIN BINDING; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 40449128522     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.094870     Document Type: Article

References (17)

1. Winters SJ, Kelley DE, Goodpaster B. The analog free testosterone assay: are the results in men clinically useful? Clin Chem 1998;44:2178-82.
2. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72.
3. Tibblin G, Adlerberth A, Lindstedt G, Bjorntorp P. The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 1996;45:1605-9.
4. Jowett T, Chu F, Ekins R. Validity of current analog-based free hormone immunoassays. Steroids 1988;52:365-6.
5. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. Am J Epidemiol 1996;143:889-97.
6. Slaats EH, Kennedy JC, Kruijswijk H. Interference of sex-hormone binding globulin in the "Coat-A-Count" testosterone no-extraction radioimmunoassay. Clin Chem 1987;33:300-2.
7. Phillips GB, Jing T-Y, Resnick LM, Barbagallo M, Laragh JH, Sealey JE. Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension. J Hypertens 1993;11:699-702.
8. Van Uytfanghe K, Stockl D, Kaufman JM, Fiers T, De Leenheer A, Thienpont LM. Validation of 5 routine assays for serum free testosterone with a candidate reference measurement procedure based on ultrafiltration and isotope dilution-gas chromatography-mass spectrometry. Clin Biochem 2005;38:253-61.
9. Greenspan FS, Gardner DG [eds]. Basic and Clinical Endocrinology. 7th ed. New York: McGraw-Hill, 2004.
10. Nelson JC, Tomei RT. Direct determination of free thyroxin in undiluted serum by equilibrium dialysis/radioimmunoassay. Clin Chem 1988;34:1737-44.
11. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 2004;89:525-33.
12. Sinha-Hikim I, Arver S, Beall G, Shen R, Guerrero M, Sattler F, Shikuma C, Nelson JC, Landgren BM, Mazer NA, Bhasin S. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 1998;83:1312-8.
13. Umstot ES, Baxter JE, Andersen RN. A theoretically sound and practicable equilibrium dialysis method for measuring percentage of free testosterone. J Steroid Biochem 1985;22:639-48.
14. Wilcox RB, Nelson JC. Time course of pH regulation in free thyroxin determinations in serum. Clin Chem 1991;37:1298-300.
15. Bhasin S, Swerdloff RS, Steiner B, Peterson MA, Meridores T, Galmirini M, Pandian MR, Goldberg R, Berman N. A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men. J Clin Endocrinol Metab 1992;74:75-83.
16. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92:405-13.
17. 4 immunoassay. Clin Chem 2007;53:911-5.